N. Anegawa

发表

N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.

T. Verdoorn, D. Lynch, D. B. Pritchett, 1994, Molecular pharmacology.

Pharmacology of Recombinant NMDA Receptors

E. Grant, D. Lynch, M. J. Gallagher, 1997 .

Opposing Contributions of NR1 and NR2 to Protein Kinase C Modulation of NMDA Receptors

D. Pleasure, B. Bacskai, E. R. Grant, 1998, Journal of neurochemistry.

Quinolinate in Brain and Cerebrospinal Fluid in Rat Models of Congenital Hyperammonemia

E. Mellits, M. Heyes, M. Robinson, 1992, Pediatric Research.

Glutamate decarboxylase messenger RNA in rat pallidum: Comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments

J. Delfs, N. Anegawa, M. Chesselet, 1995, Neuroscience.

Pharmacological Characterization of Heterodimeric NMDA Receptors Composed of NR 1a and 2B Subunits: Differences with Receptors Formed from NR 1a and 2A

M. Dichter, J. Lawrence, D. B. Pritchett, 1995, Journal of neurochemistry.

Brain Serotonin2 and Serotonin1A Receptors Are Altered in the Congenitally Hyperammonemic Sparse Fur Mouse

I. Lucki, J. Coyle, M. Robinson, 1992, Journal of neurochemistry.

N-Methyl-D-aspartate receptor mediated toxicity in nonneuronal cell lines: characterization using fluorescent measures of cell viability and reactive oxygen species production.

D. Lynch, J. Lindstrom, R. Anand, 2000, Brain research. Molecular brain research.

Transfection of N‐Methyl‐d‐Aspartate Receptors in a Nonneuronal Cell Line Leads to Cell Death

T. Verdoorn, D. B. Pritchett, N. Anegawa, 1995, Journal of neurochemistry.

The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.

M. Yudkoff, S. Hyman, M. Robinson, 1995, Gene therapy.